Macrophages and atherosclerotic plaque stability

Area of Science:

• Cardiovascular Biology
• Immunology
• Atherosclerosis Research

Background:

• Atheroma plaque rupture, a cause of coronary thrombosis, is linked to thin fibrous caps and thrombogenic lipid cores rich in macrophages.
• Monocyte-derived macrophages are critical in plaque instability, mediating processes from recruitment and lipid accumulation to matrix degradation.

Purpose of the Study:

• To elucidate the role of plaque macrophages in the instability of atheroma.
• To explore how macrophage functions influence fibrous cap integrity and lesion complication.
• To hypothesize the mechanism by which lipid-lowering therapies stabilize atherosclerotic lesions.

Main Methods:

• Review of literature on monocyte recruitment, differentiation into macrophages, and their functional properties within atherosclerotic plaques.
• Analysis of the role of macrophages in extracellular matrix degradation and fibrous cap weakening.
• Examination of the impact of macrophage apoptosis on lipid pool formation and plaque instability.

Main Results:

• Macrophages are central to atheroma pathogenesis, influencing plaque stability through lipid uptake, cytokine production, and matrix degradation.
• Macrophage-mediated degradation of the fibrous cap's collagenous matrix is a key factor in plaque rupture.
• Macrophage apoptosis contributes to the formation of a thrombogenic lipid core, correlating with plaque instability.

Conclusions:

• Macrophage functions critically influence the stability of human atheroma, particularly through their role in fibrous cap integrity.
• Targeting maladaptive macrophage functions may be a therapeutic strategy for stabilizing atherosclerotic lesions.
• Lipid-lowering therapies are hypothesized to reduce clinical events by stabilizing plaques via modulation of macrophage behavior.